HER2-positive breast cancer: Combined 18F-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after preoperative chemotherapy with trastuzumab
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | HER2-positive breast cancer: Combined 18F-FDG PET and CGFL/Curie nomogram to predict pathologic complete response after preoperative chemotherapy with trastuzumab |
Type de publication | Journal Article |
Year of Publication | 2020 |
Auteurs | Vincent L, Jankowski C, Cortet M, Arnould L, Ladoire S, Coudert B, Desmoulins I, Charron-Barra C, Beltjens F, Rouzier R, Reyal F, Humbert O, Cochet A, Coutant C |
Journal | CANCER RESEARCH |
Volume | 80 |
Date Published | FEB |
Type of Article | Meeting Abstract |
ISSN | 0008-5472 |
DOI | 10.1158/1538-7445.SABCS19-P2-16-14 |